357 related articles for article (PubMed ID: 11698484)
21. Fas ligand-mediated cytotoxicity is directly responsible for apoptosis of normal CD4+ T cells responding to a bacterial superantigen.
Ettinger R; Panka DJ; Wang JK; Stanger BZ; Ju ST; Marshak-Rothstein A
J Immunol; 1995 May; 154(9):4302-8. PubMed ID: 7536768
[TBL] [Abstract][Full Text] [Related]
22. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.
Fleck M; Zhang HG; Kern ER; Hsu HC; Müller-Ladner U; Mountz JD
Arthritis Rheum; 2001 Apr; 44(4):964-73. PubMed ID: 11315936
[TBL] [Abstract][Full Text] [Related]
23. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
Davidson WF; Haudenschild C; Kwon J; Williams MS
J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
[TBL] [Abstract][Full Text] [Related]
24. Th1 and Th2 subsets equally undergo Fas-dependent and -independent activation-induced cell death.
Watanabe N; Arase H; Kurasawa K; Iwamoto I; Kayagaki N; Yagita H; Okumura K; Miyatake S; Saito T
Eur J Immunol; 1997 Aug; 27(8):1858-64. PubMed ID: 9295019
[TBL] [Abstract][Full Text] [Related]
25. Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-gamma.
Zhang Y; Xu G; Zhang L; Roberts AI; Shi Y
J Immunol; 2008 Jul; 181(1):190-6. PubMed ID: 18566384
[TBL] [Abstract][Full Text] [Related]
26. Chronic morphine treatment promotes specific Th2 cytokine production by murine T cells in vitro via a Fas/Fas ligand-dependent mechanism.
Greeneltch KM; Kelly-Welch AE; Shi Y; Keegan AD
J Immunol; 2005 Oct; 175(8):4999-5005. PubMed ID: 16210602
[TBL] [Abstract][Full Text] [Related]
27. Modulation of Apoptosis by Cytotoxic Mediators and Cell-Survival Molecules in Sjögren's Syndrome.
Nakamura H; Horai Y; Shimizu T; Kawakami A
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103522
[TBL] [Abstract][Full Text] [Related]
28. Intracellular trafficking and surface expression of SS-A (Ro), SS-B (La), poly(ADP-ribose) polymerase and alpha-fodrin autoantigens during apoptosis in human salivary gland cells induced by tumour necrosis factor-alpha.
McArthur C; Wang Y; Veno P; Zhang J; Fiorella R
Arch Oral Biol; 2002 Jun; 47(6):443-8. PubMed ID: 12102760
[TBL] [Abstract][Full Text] [Related]
29. Detection of cleaved alpha-fodrin autoantigen in Sjögren's syndrome: apoptosis and co-localisation of cleaved alpha-fodrin with activated caspase-3 and cleaved poly(ADP-ribose) polymerase (PARP) in labial salivary glands.
Wang Y; Virji AS; Howard P; Sayani Y; Zhang J; Achu P; McArthur C
Arch Oral Biol; 2006 Jul; 51(7):558-66. PubMed ID: 16405863
[TBL] [Abstract][Full Text] [Related]
30. Fas/Fas ligand pathway, apoptosis, and clonal anergy involved in systemic acetylcholine receptor T cell epitope tolerance.
Deng C; Goluszko E; Christadoss P
J Immunol; 2001 Mar; 166(5):3458-67. PubMed ID: 11207304
[TBL] [Abstract][Full Text] [Related]
31. Protection of T cells from activation-induced cell death by Fas+ B cells.
Wang JK; Ju ST; Marshak-Rothstein A
Eur J Immunol; 2000 Mar; 30(3):931-7. PubMed ID: 10741411
[TBL] [Abstract][Full Text] [Related]
32. TCR in Fas-sensitive T cells from labial salivary glands of patients with Sjögren's syndrome.
Sumida T; Matsumoto I; Murata H; Namekawa T; Matsumura R; Tomioka H; Iwamoto I; Saito Y; Mizushima Y; Hasunuma T; Maeda T; Nishioka K
J Immunol; 1997 Jan; 158(2):1020-5. PubMed ID: 8993025
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of autoimmune diabetes by Fas ligand: the paradox is solved.
Kim S; Kim KA; Hwang DY; Lee TH; Kayagaki N; Yagita H; Lee MS
J Immunol; 2000 Mar; 164(6):2931-6. PubMed ID: 10706679
[TBL] [Abstract][Full Text] [Related]
34. Estrogen deficiency accelerates autoimmune exocrinopathy in murine Sjögren's syndrome through fas-mediated apoptosis.
Ishimaru N; Saegusa K; Yanagi K; Haneji N; Saito I; Hayashi Y
Am J Pathol; 1999 Jul; 155(1):173-81. PubMed ID: 10393849
[TBL] [Abstract][Full Text] [Related]
35. Involvement of the Fas/Fas ligand pathway in activation-induced cell death of mycobacteria-reactive human gamma delta T cells: a mechanism for the loss of gamma delta T cells in patients with pulmonary tuberculosis.
Li B; Bassiri H; Rossman MD; Kramer P; Eyuboglu AF; Torres M; Sada E; Imir T; Carding SR
J Immunol; 1998 Aug; 161(3):1558-67. PubMed ID: 9686624
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death.
Ayroldi E; Zollo O; Cannarile L; D' Adamio F; Grohmann U; Delfino DV; Riccardi C
Blood; 1998 Dec; 92(11):4212-9. PubMed ID: 9834226
[TBL] [Abstract][Full Text] [Related]
37. Increased susceptibility of Fas ligand-deficient gld mice to Trypanosoma cruzi infection due to a Th2-biased host immune response.
Lopes MF; Nunes MP; Henriques-Pons A; Giese N; Morse HC; Davidson WF; Araújo-Jorge TC; DosReis GA
Eur J Immunol; 1999 Jan; 29(1):81-9. PubMed ID: 9933089
[TBL] [Abstract][Full Text] [Related]
38. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression.
Delgado M; Ganea D
J Immunol; 2000 Feb; 164(3):1200-10. PubMed ID: 10640731
[TBL] [Abstract][Full Text] [Related]
39. The T cell in Sjogren's syndrome: force majeure, not spectateur.
Singh N; Cohen PL
J Autoimmun; 2012 Sep; 39(3):229-33. PubMed ID: 22709856
[TBL] [Abstract][Full Text] [Related]
40. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
